LAUREN CHAPPELL: Open Payments
NPI 1437691326 · PARIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$852 in 38 payments from 9 companies in 2025. Trend: 2023 $730 · 2024 $381 · 2025 $852
Food & beverage: $748Education: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $313 |
| Galderma Laboratories, L.P. | 10 | $209 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $104 |
| Janssen Biotech, Inc. | 3 | $54 |
| Lilly USA, LLC | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| UCB, Inc. | 2 | $35 |
| MIMEDX Group, Inc. | 1 | $25 |
| SpringWorks Therapeutics, Inc. | 1 | $23 |
Products named: SKYRIZI, NEMLUVIO, TREMFYA, TALTZ, Bimzelx, RINVOQ, GOMEKLI, ILUMYA.
Industry payments across TX — which companies pay providers there.
